Summary:
- The article discusses a recent study published in *JAMA Ophthalmology* identifying a potential association between semaglutide (the active ingredient in Ozempic and Wegovy) and Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION), a rare condition involving sudden vision loss due to restricted blood flow to the optic nerve.
- While the research highlights a statistically significant correlation—specifically noting a higher incidence of NAION in patients prescribed semaglutide compared to those on other weight-loss or diabetes medications—it emphasizes that the study is observational and further clinical investigation is required to establish definitive causation.